K2 Pure Solutions helps provide an answer to eliminating the need to transport chlorine for water purification and disinfection, as well as other industries, by deploying and funding a North American wide network of state-of-the-art facilities utilizing inherently safe technology. For more information, please visit: www.k2pure.com

We are improving how we farm and what we eat by unleashing the natural power that exists in plants to create a more agile and resilient agriculture system.

Arine optimizes medication therapy and treatment plans – saving one in every six healthcare dollars spent. The company's medication optimization platform aggregates and analyzes clinical, social, and behavioral data to identify and address gaps in patient care on behalf of payors and risk-bearing providers. Arine uses predictive analytics to target care to at-risk health plan members, AI to generate personalized care plans for each patient, and machine learning to continuously optimize members' medication therapy. Clients have achieved a 15% reduction in total cost of care and a 40% reduction in hospital admissions, while improving the efficiency of the care team by five- to ten-fold.

Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing treatments for immunological and inflammatory diseases that improve patients’ lives.

Love Coffee? You're in Good Company... Sightglass is an independent, sibling-owned coffee company in San Francisco. We strive to cultivate a distinct and immersive experience for both our employees and customers in and around our coffee bars. To accomplish this, we work to employ a team of truly passionate and talented individuals who possess a genuine drive, curiosity, and desire to learn about our craft and the intricacies that set us apart. If you love coffee and want to learn and grow with us, please apply for one of our current openings.

Lygos is a pioneering sustainable specialty chemicals company, leading the world’s transition toward better, cleaner, and more sustainable products. We have built a proprietary and fully integrated platform of the most advanced technologies across synthetic biology, industrial chemistry, and application development to rapidly deliver market relevant solutions to some of the world’s biggest sustainability challenges. With a pipeline of high-performing, innovative solutions, Lygos is paving the way for generations of new sustainable solutions for our world.

Charm Industrial is working to return the atmosphere to 280 ppm CO₂. We design, build and operate a fleet of mobile fast pyrolyzers that convert ag and forest biomass residues into bio-oil for use in carbon removal and direct-reduced-iron steelmaking. In 2020 our Chief Scientist and co-founder Shaun Meehan had two breakthroughs (bio-oil intermediate and bio-oil sequestration) that kickstarted the company. Within 10 months we completed our first carbon removal injection and in 2021 we completed more than 5,000 tons of CO₂e removal for customers like Stripe, Shopify and Microsoft.

For over thirty years, Excel Pest Services has been providing exceptional Residential and Commercial pest control services, servicing thousands of customers in New Jersey and South Florida. Family owned and operated, we are committed to delivering treatments that are designed to be tough on pests yet environmentally responsible and safe for family and pets. Our trained technicians are experts in pest behavior, biology, and seasonality. We know what they like and what they look for. And that’s what makes us so effective at not just getting rid of pests – but also keeping them out, 365 days a year. 100% guaranteed.

Tricida, Inc., is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (also known as TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD). Metabolic acidosis is a chronic condition commonly caused by CKD that is believed to accelerate the progression of CKD, increase the risk of muscle wasting and cause the loss of bone density. Tricida was founded in August 2013 by a seasoned management team that has extensive experience in the development and commercialization of therapeutics, with substantial expertise in developing polymers for the treatment of kidney-related diseases.